Insight Molecular Diagnostics EBITDA Margin 2014-2025 | IMDX
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Insight Molecular Diagnostics (IMDX) over the last 10 years. The current EBITDA margin for Insight Molecular Diagnostics as of March 31, 2025 is .
| Insight Molecular Diagnostics EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.00B | $-0.06B | -1866.67% |
| 2024-12-31 | $0.00B | $-0.06B | -5900.00% |
| 2024-09-30 | $0.00B | $-0.04B | 0.00% |
| 2024-06-30 | $0.00B | $-0.04B | 0.00% |
| 2024-03-31 | $0.00B | $-0.04B | 0.00% |
| 2023-12-31 | $0.00B | $-0.02B | 0.00% |
| 2023-09-30 | $0.00B | 0 | 0.00% |
| 2023-06-30 | $0.00B | $0.01B | 0.00% |
| 2023-03-31 | $0.00B | $0.01B | 0.00% |
| 2022-12-31 | $0.00B | $0.01B | 0.00% |
| 2022-09-30 | $0.00B | $-0.02B | 800.00% |
| 2022-06-30 | $0.00B | $-0.03B | 2800.00% |
| 2022-03-31 | $0.00B | $-0.04B | -4000.00% |
| 2021-12-31 | $0.00B | $-0.05B | -2450.00% |
| 2021-09-30 | $0.01B | $-0.04B | -840.00% |
| 2021-06-30 | $0.01B | $-0.04B | -700.00% |
| 2021-03-31 | $0.00B | $-0.03B | -1066.67% |
| 2020-12-31 | $0.00B | $-0.03B | -1450.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.074B | $0.002B |
| Insight Molecular Diagnostics Inc. is a pioneering diagnostics technology company. Insight Molecular Diagnostics Inc., formerly known as Oncocyte Corporation, is based in NASHVILLE, Tenn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.104B | 58.65 |
| Doximity (DOCS) | United States | $12.505B | 55.48 |
| Hims & Hers Health (HIMS) | United States | $11.626B | 96.18 |
| Tempus AI (TEM) | United States | $10.538B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.092B | 0.00 |
| Hinge Health (HNGE) | United States | $4.422B | 0.00 |
| Privia Health (PRVA) | United States | $2.526B | 187.09 |
| Inspire Medical Systems (INSP) | United States | $2.341B | 34.41 |
| Enovis (ENOV) | United States | $1.626B | 8.59 |
| Phreesia (PHR) | United States | $1.607B | 0.00 |
| 10x Genomics (TXG) | United States | $1.513B | 0.00 |
| Omnicell (OMCL) | United States | $1.416B | 27.28 |
| Schrodinger (SDGR) | United States | $1.410B | 0.00 |
| Azenta (AZTA) | United States | $1.331B | 58.06 |
| Clover Health Investments (CLOV) | United States | $1.109B | 0.00 |
| Evolent Health (EVH) | United States | $1.057B | 0.00 |
| Claritev (CTEV) | United States | $0.934B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.623B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.496B | 0.00 |
| Talkspace (TALK) | United States | $0.418B | 125.00 |
| Zepp Health (ZEPP) | Netherlands | $0.360B | 0.00 |
| Carlsmed (CARL) | $0.337B | 0.00 | |
| Butterfly Network (BFLY) | United States | $0.335B | 0.00 |
| TruBridge (TBRG) | United States | $0.284B | 49.76 |
| Nyxoah SA (NYXH) | Belgium | $0.253B | 0.00 |
| Outset Medical (OM) | United States | $0.227B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.215B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.197B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.183B | 0.00 |
| CapsoVision (CV) | United States | $0.182B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.126B | 0.00 |
| American Well (AMWL) | United States | $0.114B | 0.00 |
| CareCloud (CCLD) | United States | $0.113B | 5.14 |
| EUDA Health Holdings (EUDA) | Singapore | $0.097B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.092B | 0.00 |
| Pulmonx (LUNG) | United States | $0.063B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.048B | 0.00 |
| HeartBeam (BEAT) | United States | $0.033B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.020B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.012B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.006B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| PROFUSA (PFSA) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |